- Home
- ATYR vs URG Comparison
ATYR vs URG Comparison
Compare ATYR & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- URG
- Stock Information
- Founded
- ATYR 2005
- URG 2004
- Country
- ATYR United States
- URG United States
- Employees
- ATYR N/A
- URG N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- URG Precious Metals
- Sector
- ATYR Health Care
- URG Basic Materials
- Exchange
- ATYR Nasdaq
- URG Nasdaq
- Market Cap
- ATYR 535.0M
- URG 565.5M
- IPO Year
- ATYR 2015
- URG N/A
- Fundamental
- Price
- ATYR $1.03
- URG $1.48
- Analyst Decision
- ATYR Buy
- URG Strong Buy
- Analyst Count
- ATYR 6
- URG 3
- Target Price
- ATYR $8.88
- URG $2.63
- AVG Volume (30 Days)
- ATYR 15.6M
- URG 6.7M
- Earning Date
- ATYR 11-06-2025
- URG 11-05-2025
- Dividend Yield
- ATYR N/A
- URG N/A
- EPS Growth
- ATYR N/A
- URG N/A
- EPS
- ATYR N/A
- URG N/A
- Revenue
- ATYR N/A
- URG $39,488,000.00
- Revenue This Year
- ATYR $420.85
- URG N/A
- Revenue Next Year
- ATYR $1,919.44
- URG $232.02
- P/E Ratio
- ATYR N/A
- URG N/A
- Revenue Growth
- ATYR N/A
- URG 149.20
- 52 Week Low
- ATYR $0.97
- URG $0.55
- 52 Week High
- ATYR $7.29
- URG $1.62
- Technical
- Relative Strength Index (RSI)
- ATYR 22.25
- URG 56.96
- Support Level
- ATYR $1.00
- URG $1.42
- Resistance Level
- ATYR $6.50
- URG $1.60
- Average True Range (ATR)
- ATYR 0.46
- URG 0.08
- MACD
- ATYR -0.51
- URG -0.00
- Stochastic Oscillator
- ATYR 1.01
- URG 50.00
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.